Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

Completed · Phase 1

Conditions studied: Meningitis, Meningococcal

In brief

The purpose of this study is to evaluate the safety and tolerability of an investigational meningococcal B rLP2086 vaccine in healthy adults.

Key facts

Study ID
NCT00879814
Run by
Pfizer
People needed
48
Starts
2009-04-01
Expected to finish
2012-07-01
Last updated by the study team
2015-08-06

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.